NMG282 is a non-tumorigenic variant of fibroblast growth factor 19, an endocrine gastrointestinal hormone that regulates stomach acid and is responsible for glucose and lipid metabolism in the body. (sciencedaily.com)
Stimulation of the vagal motor nucleus, releasing 19 different gastrointestinal hormones including insulin, cholecystokinin and gastrin (Tafari and Ross, 1973). (breastcrawl.org)
«Gastrointestinal hormone measurably improved symptoms of non-alcoholic fatty liver disease: In clinical trial, treatment significantly reduced liver fat in NAFLD and NASH patients, offering possible new treatment for conditions that currently lack medical remedies.» (sciencedaily.com)